Techcyte builds an AI-powered digital pathology platform that unifies anatomic and clinical pathology workflows under its Fusion product, integrating with lab systems and supporting cytology, hematology, microbiology, parasitology, and frozen-section diagnostics. Founded in 2013 and based in Orem, Utah, the company serves human, veterinary, and environmental laboratories worldwide through partnerships with scanner makers, AI developers, and reference labs including BD, Mayo Clinic, ARUP, and Zoetis.
1
Round
5
Tags
Apr 30, 2026
Latest raise
Funding activity · 1 round
Apr 30, 2026
$15M
Series B
Led by Van Tuyl Companies
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
